KREBSBIO vs SIGACHI: Stock Comparison

Krebs Biochemicals and Industries Limited vs Sigachi Industries Limited

Live data: 22 July 2026, 3:05 PM IST • Source: NSE and company filings

Sigachi Industries Limited is the larger company by market capitalisation. Sigachi Industries Limited shows a lower P/E, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Krebs Biochemicals and Industries Limited and Sigachi Industries Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, KREBSBIO is more favourable on 3 of 11 scored metrics and SIGACHI on 7These counts are context-free and are not an overall rating.

Key Differences

Market Cap
SIGACHI is the larger company
₹1,011 Cr vs ₹117 Cr
P/E Ratio
SIGACHI has a lower P/E
-12.13x vs 0x
P/B Ratio
KREBSBIO has a lower P/B
0x vs 1.9x
EPS
SIGACHI has higher earnings per share
₹-1.46 vs ₹-7.85
Dividend Yield
SIGACHI has a higher dividend yield
0.45% vs 0%
Revenue Growth (TTM YoY)
SIGACHI has faster revenue growth
16.22% vs 11.6%
Qtr Sales Growth
KREBSBIO has stronger quarterly sales growth
11.6% vs -11.6%
Qtr Profit Growth
KREBSBIO has stronger quarterly profit growth
71.7% vs -70.9%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKREBSBIOSIGACHI
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricKREBSBIOSIGACHI
Live Price₹53.41₹21.03
Day Change-3.03%-4.23%
Volume1,99732.76 L
52-Week High₹82.49₹46.73
52-Week Low₹38.33₹16.65
Distance from 52W High-35.25%-55%

Valuation

MetricKREBSBIOSIGACHI
Market Cap₹117 Cr₹1,011 Cr
P/E Ratio0x-12.13x
P/B Ratio0x1.9x
EPS₹-7.85₹-1.46
Book Value₹-75.5₹15.72
Dividend Yield0%0.45%

Growth

MetricKREBSBIOSIGACHI
Revenue Growth (TTM YoY)11.6%16.22%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth11.6%-11.6%
Qtr Profit Growth71.7%-70.9%

Profitability & Leverage

MetricKREBSBIOSIGACHI
ROE-15.66%
ROCE-15.4%15.5%
Net Margin-71.35%-17.33%
Operating Margin-23%-15.44%
Debt to Equity0.26x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKREBSBIOSIGACHI
Promoter Holding72.74%36.69% 3.01 pp
FII Holding0.5%1.3% 2.03 pp
DII Holding0%0%
Public Holding26.76%62.01% 5.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Krebs Biochemicals and Industries Limited and Sigachi Industries Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.